Reaction products of 2,4,6-trichloro-1,3,5-triazine copuled with 3-aminopropyldiethylamine, coupled with 3-acetamidoanilinium chloride, diazotised, coupled with 2,5-Xylidine, coupled with 3-amino-4-hydroxybenzenesulphonamide, further coupled with resorcinol and metallized with iron chloride.

Endpoint summary

Description of key information

Oral LD50 (male and female): 2730 mg/kg bw ± 233 mg

Key value for chemical safety assessment

Acute toxicity: via oral route

Link to relevant study records

Reference

Endpoint:

acute toxicity: oral

Type of information:

experimental study

Adequacy of study:

key study

Reliability:

2 (reliable with restrictions)

Rationale for reliability incl. deficiencies:

study well documented, meets generally accepted scientific principles, acceptable for assessment

Qualifier:

equivalent or similar to guideline

Guideline:

OECD Guideline 401 (Acute Oral Toxicity)

GLP compliance:

no

Test type:

standard acute method

Limit test:

no

Species:

rat

Strain:

Wistar

Sex:

male/female

Details on test animals or test system and environmental conditions:

TEST ANIMALS
- Source: KFM, CH-4414 Fullinsdorf, Switzerland.
- Age at study initiation: young adult, age not specified.
- Weight at study initiation: ranged between 150 and 200 g.
- Fasting period before study: access of food only was prevented approximately 18 hours prior and four hours aiter the dosing. The water bottles were with-drawn two hours prior and four hours after dosing.
- Housing: rats were housed individually in Macrolon cages.
- Diet: standard laboratory pelleted diet (KLIBA no. 24-343-4 from Klingentalmuhle AG., Basle), ad libitum. The batch of diet used for the study was analysed for chemical and microbiological contaminants.
- Water: ad libitum.
- Acclimation period: animals were acclimatised to the experimental environment for a period of about five days prior to the start of the study.

ENVIRONMENTAL CONDITIONS
- Temperature: 23 ± 2 °C
- Humidity: 30 - 70 %
- Air changes: approximately 15 changes/hour.
- Photoperiod: 12 hrs dark / 12 hrs light.

Route of administration:

oral: gavage

Vehicle:

DMSO

Details on oral exposure:

Dosed volume: 15 ml per kg body weight.

Doses:

1600, 2500, 3200 and 4000 mg/kg bw

No. of animals per sex per dose:

five male and five female rats

Details on study design:

- Duration of observation period following administration: 14 days
- Frequency of observations: animals were observed soon after dosing, then at hourly intervals for the remainder day 1. On the subsequent days the animals were observed once in the morning and once in the late afternoon. Clinical signs were recorded at each observation.
- Frequency of weighing: individual body weights on day 1, 7 and 14.
- Necropsy of survivors performed: yes. Surviving animals were killed after two weeks. All animals which died during the study and those killed after two weeks were subjected to a macroscopic postmortem examination. The macroscopic appearance of the abnormal organs was recorded.

DOSE SELECTION
A preliminary study was carried out to establish a dosing regimen, using groups of two males and two females at three dosages, using 10 - 15 ml/kg body weight.

Preliminary study:

Mortality: at 1000 mg/kg bw 0 %; at 2400 mg/kg bw 50 %; at 4800 mg/kg bw 100 %

Sex:

male/female

Dose descriptor:

LD50

Effect level:

2 730 mg/kg bw

Based on:

test mat.

Mortality:

Mortality: at 1600 mg/kg bw 20 %; at 2500 mg/kg bw 30 %; at 3200 mg/kg bw 60 %; at 4000 mg/kg bw 90 %

Clinical signs:

The animals were weak and dazed and their movement decreased. Labored respiration.

Gross pathology:

No special findings

Cumulative mortality

Dose	No males died	No females died	Mortality %
1600	1	1	20
2500	1	2	30
3200	4	2	60
4000	4	5	90

Sex	Dose	Mortality ratio	Time of death after dosing
Males	1600	1/5	50'
	2500	1/5	58'
	3200	4/5	55', 3.5h, 4.5h, 4.5h
	4000	4/5	36', 45', 4h, 5h
Females	1600	1/5	-
	2500	2/5	50', 4.5h
	3200	2/5	35', 6h
	4000	5/5	30', 53', 91', 5h, 5.5h

Interpretation of results:

other: not classified, according to the CLP Regulation (EC 1272/2008)

Conclusions:

LD50 (male and female): 2730 mg/kg bw ± 233 mg

Executive summary:

The study was performed to assess the acute oral toxicity of the test material in the Han-Wistar rat. Following a range-finding study, fours groups of ten fasted animals (five males and five females) were given the following oral doses (test item in DMSO): 1600, 2500, 3200 and 4000 mg/kg bw.

The animals were observed for fourteen days after the day of dosing and were then killed for gross pathological examination.

Mortality resulted to be 20 % at 1600 mg/kg bw, 30 % at 2500 mg/kg bw, 60 % at 3200 mg/kg bw and 90 % at 4000 mg/kg bw. The animals were weak and dazed and their movement decreased. Labored respiration. No special findings were recorded from pathology examination.

Conclusion

LD50 (male and female): 2730 mg/kg bw ± 233 mg

Endpoint conclusion

Endpoint conclusion:

no adverse effect observed

Dose descriptor:

LD50

Value:

2 730 mg/kg bw

Acute toxicity: via inhalation route

Endpoint conclusion

Endpoint conclusion:

no study available

Acute toxicity: via dermal route

Endpoint conclusion

Endpoint conclusion:

no study available

Additional information

ORAL ACUTE TOXICITY

The study was performed to assess the acute oral toxicity of the test material in the Han-Wistar rat. Following a range-finding study, fours groups of ten fasted animals (five males and five females) were given the following oral doses (test item in DMSO): 1600, 2500, 3200 and 4000 mg/kg bw. The animals were observed for fourteen days after the day of dosing and were then killed for gross pathological examination.

Mortality resulted to be 20 % at 1600 mg/kg bw, 30 % at 2500 mg/kg bw, 60 % at 3200 mg/kg bw and 90 % at 4000 mg/kg bw. The animals were weak and dazed and their movement decreased. Labored respiration. No special findings were recorded from pathology examination.

Justification for classification or non-classification

According to the CLP Regulation (EC) No 1272/2008, 3.1 Acute toxicity section, substances can be allocated to one of four toxicity categories based on acute toxicity by the oral, dermal or inhalation route according to the numeric criteria. Acute toxicity values are expressed as (approximate) LD50 (oral, dermal) or LC50 (inhalation) values or as acute toxicity estimates (ATE).

 

The oral LD50 value was established to be greater than 2000 mg/kg, therefore the test substance is out of any classification limit for acute oral toxicity (oral acute toxicity category 4: 300 < ATE ≤ 2000 mg/kg bw).